Orchestra BioMed Holdings, Inc. (OBIO) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2022: $211.0K2023: $186.0K2024: $204.0K2025: $190.0K$190.0K
2022Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$190.0K-6.9%
2024$204.0K+9.7%
2023$186.0K-11.8%
2022$211.0K